Literature DB >> 6206071

In vivo and in vitro binding of 1,2-dibromoethane and 1,2-dichloroethane to macromolecules in rat and mouse organs.

G Arfellini, S Bartoli, A Colacci, M Mazzullo, M C Galli, G Prodi, S Grilli.   

Abstract

The comparative interaction of equimolar amounts of 1,2-dichloroethane and 1,2-dibromoethane with rat and mouse nucleic acids was studied in both in vivo (liver, lung, kidney and stomach) and in vitro (liver microsomal and/or cytosolic fractions) systems. In vivo, liver and kidney DNA showed the highest labeling, whereas the binding to lung DNA was barely detectable. Dibromoethane was more highly reactive than dichloroethane in both species. With dichloroethane, mouse DNA labeling was higher than rat DNA labeling whatever the organ considered: the opposite was seen for the bioactivation of dibromoethane. RNA and protein labelings were higher than DNA labeling, with no particular pattern in terms of organ or species involvement. In vitro, in addition to a low chemical reactivity towards nucleic acids shown by haloethanes per se, both compounds were bioactivated by either liver microsomes and cytosolic fractions to reactive forms capable of binding to DNA and polynucleotides. UV irradiation did not photoactivate dibromoethane and dichloroethane. The in vitro interaction with DNA mediated by enzymatic fractions was PB-inducible (one order of magnitude, using rat microsomes). In vitro bioactivation of haloethanes was mainly performed by microsomes in the case of dichloroethane and by cytosolic fractions in the case of dibromoethane. When microsomes plus cytosol were used, rat enzymes were more efficient than mouse enzymes in inducing a dibromoethane-DNA interaction: the opposite situation occurred for dichloroethane-DNA interaction, and this is in agreement with the in vivo pattern. In the presence of both metabolic pathways, addition or synergism occurred. Dibromoethane was always more reactive than dichloroethane. An indication of the presence of a microsomal GSH transferase was achieved for the activation of dibromoethane. No preferential binding in vitro to a specific polynucleotide was found. Polynucleotide labeling was higher than (or equal to) DNA binding. The labeling of microsomal RNA and proteins and of cytosolic proteins was many times lower than that of DNA or polynucleotides. The in vivo and in vitro data reported above give an unequivocal indication of the relative reactivity of the haloethanes examined with liver macromolecules from the two species and agree, on the whole, with the relative genotoxicity (DNA repair induction ability, mutagenicity and carcinogenicity) of the chemicals.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206071     DOI: 10.1007/bf00402468

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  25 in total

1.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

2.  Macromolecular binding and metabolism of the carcinogen 1,2-dibromoethane.

Authors:  D L Hill; T W Shih; T P Johnston; R F Struck
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

Review 3.  1,2-Dichloroethane.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risk Chem Hum       Date:  1979-10

4.  In vitro activation of 1,2-dichloroethane by microsomal and cytosolic enzymes.

Authors:  F P Guengerich; W M Crawford; J Y Domoradzki; T L Macdonald; P G Watanabe
Journal:  Toxicol Appl Pharmacol       Date:  1980-09-15       Impact factor: 4.219

5.  The relation between the structure of vicinal dihalogen compounds and their mutagenic activation via conjugation to glutathione.

Authors:  P J van Bladeren; D D Breimer; G M Rotteveel-Smijs; P de Knijff; G R Mohn; B van Meeteren-Wälchli; W Buijs; A van der Gen
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

6.  In vitro metabolism of 1,2-dihaloethanes to ethylene.

Authors:  J C Livesey; M W Anders
Journal:  Drug Metab Dispos       Date:  1979 Jul-Aug       Impact factor: 3.922

7.  Aryl hydrocarbon hydroxylase and polycyclic hydrocarbon tumorigenesis: effect of the enzyme inhibitor 7,8-benzoflavone on tumorigenesis and macromolecule binding.

Authors:  N Kinoshita; H V Gelboin
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

Review 8.  Nitrofural (nitrofurazone).

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  1990

9.  Microsome-mediated covalent binding of 1,2-dichloroethane to lung microsomal protein and salmon sperm DNA.

Authors:  S Banerjee; B L Van Duuren; F I Oruambo
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

10.  DNA damage by haloalkanes in human lymphocytes cultured in vitro.

Authors:  P Perocco; G Prodi
Journal:  Cancer Lett       Date:  1981-08       Impact factor: 8.679

View more
  5 in total

1.  Effect of inhalation exposure regimen on DNA binding potency of 1,2-dichloroethane in the rat.

Authors:  A Baertsch; W K Lutz; C Schlatter
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  In vitro microsome- and cytosol-mediated binding of 1,2-dichloroethane and 1,2-dibromoethane with DNA.

Authors:  A Colacci; M Mazzullo; G Arfellini; G Prodi; S Grilli
Journal:  Cell Biol Toxicol       Date:  1985-01       Impact factor: 6.691

3.  Quantitative predictability of carcinogenicity of the covalent binding index of chemicals to DNA: comparison of the in vivo and in vitro assays.

Authors:  M Taningher; G Saccomanno; L Santi; S Grilli; S Parodi
Journal:  Environ Health Perspect       Date:  1990-03       Impact factor: 9.031

4.  In vitro transformation of BALB/c 3T3 cells by 1,1,2,2-tetrachloroethane.

Authors:  A Colacci; P Perocco; M Vaccari; M Mazzullo; A Albini; S Parodi; M Taningher; S Grilli
Journal:  Jpn J Cancer Res       Date:  1990-08

5.  1,2-Dibromoethane as an initiating agent for cell transformation.

Authors:  A Colacci; P Perocco; M Vaccari; C Da Vià; P Silingardi; E Manzini; W Horn; S Bartoli; S Grilli
Journal:  Jpn J Cancer Res       Date:  1995-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.